These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1171496)

  • 1. The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
    Voith K; Herr F
    Psychopharmacologia; 1975 Apr; 42(1):11-20. PubMed ID: 1171496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral studies on the enantiomers of butaclamol demonstrating absolute optical specificity for neuroleptic activity.
    Voith K; Cummings JR
    Can J Physiol Pharmacol; 1976 Aug; 54(4):551-60. PubMed ID: 10059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptics related to butaclamol. Synthesis and some psychopharmacological effects of a series of 3-aryl analogues.
    Voith K; Bruderlein FT; Humber LG
    J Med Chem; 1978 Jul; 21(7):694-8. PubMed ID: 27637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1. Syntheses and stereochemical and structural requirements for activity of butaclamol and related compounds.
    Bruderlein FT; Humber LG
    J Med Chem; 1975 Feb; 18(2):185-8. PubMed ID: 1168258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptics related to butaclamol. An investigation of the effects of chlorine substituents on the aromatic rings.
    Humber LG; Sideridis N; Asselin AA; Bruderlein FT; Voith K
    J Med Chem; 1978 Dec; 21(12):1225-31. PubMed ID: 31480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):69-74. PubMed ID: 1172258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of new neuroleptic compounds.
    Coscia L; Causa P; Giuliani E; Nunziata A
    Arzneimittelforschung; 1975 Sep; 25(9):1436-42. PubMed ID: 25
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
    Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the dopamine receptor. 1. Features derived from modifications in ring E of the neuroleptic butaclamol.
    Humber LG; Bruderlein FT; Philipp AH; Götz M
    J Med Chem; 1979 Jul; 22(7):761-7. PubMed ID: 571916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of a new potent, long acting neuroleptic, piflutixol.
    Nielsen IM; Boeck V; Christensen AV; Danneskiold-Samsoe P; Hyttel J; Langeland J; Pedersen V; Svendsen O
    Acta Pharmacol Toxicol (Copenh); 1977 Oct; 41(4):369-83. PubMed ID: 579063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
    Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
    Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
    [No Abstract]   [Full Text] [Related]  

  • 12. Mapping the dopamine receptor. 2. Features derived from modifications in the rings A/B region of the neuroleptic butaclamol.
    Philipp AH; Humber LG; Voith K
    J Med Chem; 1979 Jul; 22(7):768-73. PubMed ID: 571917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of neuroleptics upon repeated administration.
    Moller Nielsen I; Fjalland B; Pedersen V; Nymark M
    Psychopharmacologia; 1974 Jan; 34(2):95-104. PubMed ID: 4856370
    [No Abstract]   [Full Text] [Related]  

  • 14. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM
    Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat.
    Bloss JL; Singer GH
    Psychopharmacology (Berl); 1978 May; 57(3):295-302. PubMed ID: 97712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurotropic properties of fluphenazine].
    Liubimov BI; Raevskiĭ KS; Ostrovskaia RU; Barkov NK; Krolevets GN
    Farmakol Toksikol; 1971; 34(3):287-90. PubMed ID: 5106035
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychopharmacological effects of thiothixene and related compounds.
    Weissman A
    Psychopharmacologia; 1968; 12(2):142-57. PubMed ID: 4385364
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central effects of some adreno- and-or sympatholytic substances. 3. Ptosis, catalepsy, antagonism with respect to apomorphine and amphetamine].
    Boissier JR; Simon P; Giudicelli JF
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):68-80. PubMed ID: 5689547
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum.
    Pycock C; Tarsy D; Marsden CD
    Psychopharmacologia; 1975 Dec; 45(2):211-9. PubMed ID: 1240638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.